Complications of Autoimmune Hemolytic Anemia.
Hematol Oncol Clin North Am
; 36(2): 353-363, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1734426
ABSTRACT
Autoimmune hemolytic anemia (AHIA) is the group of acquired autoimmune conditions resulting from the development of autologous antibodies directed against autologous red blood cell antigens resulting in red cell lysis. Beyond the presence, severity, and duration of hemolysis which can lead to symptomatic anemia, additional complications at presentation and during treatment require a high degree of clinical vigilance. These include among others cutaneous, thrombotic, renal disorders, and infectious disorders. Complications can be due to the presence of the pathologic antibody itself, the process of hemolysis, or attributed to treatment. Comprehensive management of AIHA requires awareness and assessment of complications at diagnosis, during, and following treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Hematopoietic Stem Cell Transplantation
/
Anemia, Hemolytic, Autoimmune
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Hematol Oncol Clin North Am
Journal subject:
Hematology
/
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
J.hoc.2021.12.003
Similar
MEDLINE
...
LILACS
LIS